Tuesday 17th May 2016
National Event in London
EULAR’s 2016 annual congress is at the Excel Centre in London, commencing 8th June, Wednesday afternoon and closing on Saturday 11th June.
Friday 13th May 2016
Phase 2 Trial Suggests Tocilizumab May Be of Benefit to Systemic Sclerosis Patients
Wednesday 11th May 2016
Protein, Netrin-1, Seen to Promote Lung Fibrosis in Early Scleroderma Study
Friday 6th May 2016
Cumberland Readying a Phase 2 Trial of Oral Drug, Ifetroban, to Treat Scleroderma
Cumberland Pharmaceuticals, Inc., recently announced the addition to its drug pipeline of Vasculan (ifetroban), an oral capsule that soon will enter clinical testing as a treatment of systemic sclerosis (SSc), or scleroderma.
Friday 6th May 2016
Scleroderma and Raynaud's in the Uttoxeter Advertiser
Tuesday 26th April 2016
Drug-induced Raynaud’s phenomenon is ‘probably underestimated'
Raynaud's phenomenon can be triggered or worsened by certain drugs, such as beta blockers. But knowledge about the condition is limited.
Tuesday 26th April 2016
M10 Peptide Shows Anti-Fibrotic Activity in Mice
Researchers recently discovered a natural molecule, the M10 peptide, that can significantly decrease fibrosis in a mouse model of scleroderma.
Tuesday 19th April 2016
Largest scleroderma study to date has created a complete genetic map of the disease
Friday 15th April 2016
How I Manage My Auto Immune Diseases Without Medication
Well! It’s not easy but I have managed it with a few changes over the years to my nutrition and a good exercise plan.
Thursday 14th April 2016